Robert A. Wiley

635 total citations
40 papers, 495 citations indexed

About

Robert A. Wiley is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Robert A. Wiley has authored 40 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 10 papers in Molecular Biology and 10 papers in Pharmacology. Recurrent topics in Robert A. Wiley's work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Robert A. Wiley is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Robert A. Wiley collaborates with scholars based in United States. Robert A. Wiley's co-authors include Daniel H. Rich, Robert P. Hanzlik, George J. Traiger, Larry A. Sternson, David W. Gottschall, Eugéne C. Jorgensen, Sangeetha Narasimhan, Edward J. Walaszek, Paul Weller and Hènry A. Sasame and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and British Journal of Pharmacology.

In The Last Decade

Robert A. Wiley

38 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert A. Wiley United States	11	242	168	100	69	45	40	495
H Graf Germany	15	275 1.1×	110 0.7×	131 1.3×	76 1.1×	51 1.1×	23	565
B. Paul United States	9	237 1.0×	136 0.8×	64 0.6×	59 0.9×	15 0.3×	18	460
John J. Partridge United States	17	325 1.3×	402 2.4×	66 0.7×	45 0.7×	44 1.0×	26	871
R. B. Kelly Canada	16	315 1.3×	318 1.9×	59 0.6×	58 0.8×	163 3.6×	37	622
David G. Loughhead United States	11	207 0.9×	174 1.0×	63 0.6×	30 0.4×	82 1.8×	13	423
Shouzhong Lin United States	7	241 1.0×	305 1.8×	35 0.3×	53 0.8×	57 1.3×	7	550
Keith Huie United States	13	165 0.7×	200 1.2×	91 0.9×	61 0.9×	88 2.0×	32	547
Mitsunori Ono Japan	14	240 1.0×	314 1.9×	129 1.3×	34 0.5×	22 0.5×	46	642
Harry B. Wood United States	15	334 1.4×	298 1.8×	36 0.4×	66 1.0×	85 1.9×	28	782
Robert W. Roth United States	13	185 0.8×	157 0.9×	70 0.7×	38 0.6×	26 0.6×	30	489

Countries citing papers authored by Robert A. Wiley

Since Specialization

Citations

This map shows the geographic impact of Robert A. Wiley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Wiley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Wiley more than expected).

Fields of papers citing papers by Robert A. Wiley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Wiley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Wiley. The network helps show where Robert A. Wiley may publish in the future.

Co-authorship network of co-authors of Robert A. Wiley

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Wiley. A scholar is included among the top collaborators of Robert A. Wiley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Wiley. Robert A. Wiley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wiley, Robert A. & Daniel H. Rich. (1993). Peptidomimetics derived from natural products. Medicinal Research Reviews. 13(3). 327–384. 171 indexed citations

Brinkman, R., et al.. (1990). Toxicity of alkyldihydrofurans to metabolically active organs in the mouse. Toxicology. 61(1). 47–57. 1 indexed citations

Wiley, Robert A., et al.. (1989). Darmstoff analogs. 3. Actions of choline esters of acetal phosphatidic acids on visceral smooth muscle. Journal of Medicinal Chemistry. 32(6). 1319–1322. 6 indexed citations

Narasimhan, Sangeetha, et al.. (1988). Microsomal metabolism and covalent binding of [³H/¹⁴C]-bromobenzene. Evidence for quinones as reactive metabolites. Xenobiotica. 18(5). 491–499. 32 indexed citations

Wiley, Robert A.. (1986). A Viable College of Pharmacy in the Year 2000. American Journal of Pharmaceutical Education. 50(4). 359–361. 1 indexed citations

Wiley, Robert A., et al.. (1984). A General Synthesis for 4-Alkyl-2,3-dihydrofurans. Synthesis. 1984(8). 695–697. 9 indexed citations

Wiley, Robert A., et al.. (1984). Toxicity-distribution relationships among 3-alkylfurans in mouse liver and kidney. Toxicology and Applied Pharmacology. 74(1). 1–9. 20 indexed citations

Gottschall, David W., Robert A. Wiley, & Robert P. Hanzlik. (1983). Toxicity of ortho-substituted bromobenzenes to isolated hepatocytes: Comparison to in Vivo results. Toxicology and Applied Pharmacology. 69(1). 55–65. 16 indexed citations

Wiley, Robert A., et al.. (1983). A convenient synthesis for 3-alkyl- and 3-alkenylfurans, including perillene. The Journal of Organic Chemistry. 48(7). 1106–1107. 12 indexed citations

10.

Maguire, M. Helen, et al.. (1983). Acetal phosphatidic acids: novel platelet aggregating agents. British Journal of Pharmacology. 79(1). 157–166. 8 indexed citations

11.

Hanzlik, Robert P., et al.. (1982). Toxicity and Covalent Binding of Substituted Bromobenzenes to Isolated Hepatocytes. Advances in experimental medicine and biology. 136 Pt A. 381–386. 7 indexed citations

12.

Wiley, Robert A., et al.. (1979). Effect of substituents on in vitro metabolism and covalent binding of substituted bromobenzenes. Toxicology and Applied Pharmacology. 49(2). 249–255. 23 indexed citations

13.

Hanzlik, Robert P., et al.. (1979). Tritium and deuterium exchange‐labeling of aromatic and organometallic compounds in heptafluorobutyric acid. Journal of Labelled Compounds and Radiopharmaceuticals. 16(4). 523–529. 14 indexed citations

14.

Hanzlik, Robert P., et al.. (1979). Synthesis of tritiated bromobenzene derivatives. Journal of Labelled Compounds and Radiopharmaceuticals. 16(4). 531–535. 4 indexed citations

15.

Traiger, George J., et al.. (1977). Effect of substituents on arene oxide-mediated liver toxicity among substituted bromobenzenes. Toxicology and Applied Pharmacology. 40(3). 415–425. 17 indexed citations

16.

Wiley, Robert A., D. D. Sumner, & Edward J. Walaszek. (1970). Structure determinations and synthesis of pharmacologically active phospholipids from kidney and intestine. Lipids. 5(10). 803–811. 13 indexed citations

17.

Wiley, Robert A., et al.. (1969). Phosphorus analogs of nitrogenous drugs. II. 10H-Dibenzo[1,4]thiaphosphorins as central nervous system depressants. Journal of Medicinal Chemistry. 12(1). 146–149. 1 indexed citations

18.

Wiley, Robert A., et al.. (1969). Receptor binding of the analgetic aryl moiety. I. .alpha.-Prodine analogs. Journal of Medicinal Chemistry. 12(5). 922–923. 1 indexed citations

19.

Wiley, Robert A., et al.. (1967). Double Isotopic Labeling in Toxicological Analysis I. Strychnine in Blood—A Preliminary Report. Journal of Pharmaceutical Sciences. 56(1). 144–145. 2 indexed citations

20.

Jorgensen, Eugéne C. & Robert A. Wiley. (1962). Thyroxine Analogs. VIII.¹ 3-Methyl- and 3,5-Dimethyl-DL-thyronines and Iodinated Derivatives. Journal of Medicinal Chemistry. 5(6). 1307–1315. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact